[C:1]([NH:4][C:5]1[CH:6]=[C:7]([CH:10]=[CH:11][CH:12]=1)[CH2:8]Cl)(=[O:3])[CH3:2].[OH:13][C:14]1[CH:19]=[CH:18][C:17]([C:20]2[N:25]=[C:24]([C:26]#[N:27])[C:23]3[N:28]=[CH:29][N:30](C)[C:22]=3[CH:21]=2)=[CH:16][C:15]=1[C:32]([F:35])([F:34])[F:33].[I-].[Na+].C(=O)([O-])[O-].[K+].[K+]>C(#N)C.O>[C:1]([NH:4][C:5]1[CH:6]=[C:7]([CH:10]=[CH:11][CH:12]=1)[CH2:8][O:13][C:14]1[CH:19]=[CH:18][C:17]([C:20]2[N:25]=[C:24]([C:26]#[N:27])[C:23]3[N:28]=[CH:29][NH:30][C:22]=3[CH:21]=2)=[CH:16][C:15]=1[C:32]([F:35])([F:34])[F:33])(=[O:3])[CH3:2]A mixture of 3-acetylaminobenzylchloride (200 mg), 6-(4-hydroxy-3-(trifluoromethyl)-phenyl)-1-methyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile (350 mg), sodium iodide (16 mg) and potassium carbonate (300 mg) in acetonitrile (20 ml) was heated at 80° C. for 14 hours. After cooling to room temperature, water (30 ml) was added, the white precipitate collected by filtration was dissolved in DMSO (1 ml) and purified by HPLC to give 6-(4-(3-acetylaminobenzoxy)-3-(trifluoromethyl)phenyl)-1H-imidazo[4,5-c]pyridine-4-carbonitrile. 1H NMR (DMSO) δ: 8.71 (s, 1H), 8.64 (s, 1H), 8.43 (m, 2H), 7.74 (s, 1H), 7.51 (m, 2H), 7.33 (t, 1H), 7.15 (d, 1H), 5.34 (s, 2H), 3.98 (s, 3H), 2.04 (s, 3H). MS m/z 466 (M+1).